Clinical trial
Comparison Between Ropivacaine/Dexamethasone and 10% Lignocaine Injection in Distal Glossopharyngeal Nerve Block for Intractable Cancer Pain- A Randomized Trial
NCT04085120 is registered in ClinicalTrials.gov with All India Institute of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison Between Ropivacaine/Dexamethasone and 10% Lignocaine Injection in Distal Glossopharyngeal Nerve Block for Intractable Cancer Pain- A Randomized Trial
- Lead sponsor
- All India Institute of Medical Sciences
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 23, 2019
- Completion date
- February 28, 2020
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer pain, cancer, oropharynx, pain, intractable